داروسازی تهران شیمی
شتهران | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Closed
Last Price: 1,000 0.00
Close Price: 6,830
Financial Ratios
AGM
Interim
2026/05/02 Fiscal Year 2025/12/2112 Month | 2025/10/04 Fiscal Year 2024/12/2012 Month | 2024/10/02 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 20.7 | 6.81 | 32.49 | |
Gross Profit to Sales | 23.87 | 7.33 | 33.21 | |
Operating Margin | 29.35 | 18.99 | 33.03 | |
Gross Profit to Sales | 34.19 | 24.9 | 36.25 | |
Net Profit to Gross Profit | 60.55 | 27.37 | 89.64 | |
Return on Assets (ROA) | 9.23 | 2.84 | 17.95 | |
Return on Capital (%) | 126.24 | 28.76 | 141.62 | |
Return on Equity (ROE) | 35.28 | 11.66 | 57.15 | |
Working Capital Return | 38.4 | 11.56 | 54.75 | |
Fixed Asset Return | 74.47 | 33.1 | 204.73 | |
Loan Benefit Assessment | 3.82 | 4.11 | 3.18 | |
Current Ratio | 1.43 | 1.42 | 1.68 | |
Quick Ratio | 0.94 | 0.99 | 1.32 | |
Liquidity Ratio | 0.08 | 0.09 | 0.17 | |
Net Working Capital | 22,044,480 | 16,681,156 | 17,344,334 | |
Current Assets Ratio | 0.8 | 0.83 | 0.81 | |
Inventory Turnover | 285.72 | 226.07 | 152.8 | |
Receivables Collection Period | 298.11 | 280.43 | 235.43 | |
Inventory to Working Capital | 1.14 | 1.02 | 0.54 | |
Working Capital Turnover | 1.85 | 1.7 | 1.68 | |
Fixed Asset Turnover | 3.6 | 4.86 | 6.3 | |
Total Asset Turnover | 0.45 | 0.42 | 0.55 | |
Debt Ratio | 0.74 | 0.76 | 0.69 | |
Debt to Equity | 2.82 | 3.11 | 2.18 | |
Long-Term Debt to Equity | 0.7 | 0.7 | 0.66 | |
Current Debt to Equity | 2.13 | 2.41 | 1.52 | |
Equity Ratio | 26.15 | 24.32 | 31.4 | |
Debt Coverage Ratio | 0.68 | 0.5 | 0.42 |
